Recent News

• 03.12.2026 - Vaxart Provides Business Update and Reports Full Year 2025 Financial Results
• 03.03.2026 - Vaxart to Host Upcoming Conference Calls
• 02.18.2026 - Vaxart to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference on February 25, 2026
• 01.15.2026 - Vaxart Publishes Positive Data for its Oral Bivalent Norovirus Candidate in Lactating Women and Their Infants
• 01.15.2026 - Vaxart Publishes Positive Data for its Oral Bivalent Norovirus Candidate in Lactating Women and Their Infants
• 01.08.2026 - Vaxart to Participate in the Global BioInnovation Forum on January 13, 2026
• 01.08.2026 - Vaxart to Participate in the Global BioInnovation Forum on January 13, 2026
• 11.13.2025 - Vaxart Provides Business Update and Reports Third Quarter 2025 Financial Results

Recent Filings

• 03.13.2026 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 03.12.2026 - EX-99.1 EX-99.1
• 03.12.2026 - 8-K Current report
• 02.05.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.05.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.05.2026 - 4 Statement of changes in beneficial ownership of securities
• 12.29.2025 - 8-K Current report
• 12.08.2025 - 4 Statement of changes in beneficial ownership of securities
• 12.08.2025 - 144 Report of proposed sale of securities
• 12.05.2025 - 4 Statement of changes in beneficial ownership of securities